Benefit-risk evaluation in drug licensing decisions: current European status

Activiteit: Professional or public presentation › Professional

Description

Presentation/workshop during SIR European Regulatory Affairs (ERA) course
Periode17-jan.-2018
Gehouden opSIR Institute for Pharmacy Practice and Policy, Netherlands
Mate van erkenningNational

Documenten & links